pRS425ADS Citations (2)

Originally described in: Production of the antimalarial drug precursor artemisinic acid in engineered yeast.
Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, Chang MC, Withers ST, Shiba Y, Sarpong R, Keasling JD Nature. 2006 Apr 13. 440(7086):940-3. PubMed Journal

---

Articles Citing pRS425ADS

Articles
Combination of ERG9 Repression and Enzyme Fusion Technology for Improved Production of Amorphadiene in Saccharomyces cerevisiae. Baadhe RR, Mekala NK, Parcha SR, Prameela Devi Y. J Anal Methods Chem. 2013;2013:140469. doi: 10.1155/2013/140469. Epub 2013 Oct 27. PubMed
Enhanced isoprenoid production from xylose by engineered Saccharomyces cerevisiae. Kwak S, Kim SR, Xu H, Zhang GC, Lane S, Kim H, Jin YS. Biotechnol Bioeng. 2017 Jul 1. doi: 10.1002/bit.26369. PubMed

If you have published an article using this material, please email us at to have your article added to this page.